Viyash Scientifi

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: VIYASH
  • BSEID: 512529
INR
252.10
23.2 (10.14%)
BSENSE

May 20

BSE+NSE Vol: 2.45 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Alivus Life
Sanofi Consumer
Viyash Scientifi
Strides Pharma
Akums Drugs
Marksans Pharma
Shilpa Medicare
Corona Remedies
P & G Health Ltd
Blue Jet Health
Concord Biotech

Why is Viyash Scientific Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 7.40%
  • Poor long term growth as Net Sales has grown by an annual rate of 14.17% and Operating profit at 12.25% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.32 times
2
With a growth in Net Profit of 539.5%, the company declared Outstanding results in Mar 26
  • The company has declared positive results for the last 9 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 12.69 times
  • PAT(Q) At Rs 52.11 cr has Grown at 446.4%
  • NET SALES(Q) Highest at Rs 919.96 cr
3
With ROCE of 18.1, it has a Expensive valuation with a 9.3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 49.00%, its profits have risen by 171.8% ; the PEG ratio of the company is 1
4
Majority shareholders : Promoters
5
Consistent Returns over the last 3 years
  • Along with generating 49.00% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Viyash Scientifi should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Viyash Scientifi for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Viyash Scientifi
49.0%
1.19
41.19%
Sensex
-7.23%
-0.56
13.01%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
17.40%
EBIT Growth (5y)
18.70%
EBIT to Interest (avg)
2.11
Debt to EBITDA (avg)
9.75
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
1.38
Tax Ratio
37.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.93%
ROCE (avg)
6.30%
ROE (avg)
5.97%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
58
Industry P/E
35
Price to Book Value
13.61
EV to EBIT
29.16
EV to EBITDA
19.53
EV to Capital Employed
9.31
EV to Sales
3.72
PEG Ratio
1.04
Dividend Yield
NA
ROCE (Latest)
18.12%
ROE (Latest)
15.86%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

34What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 12.69 times

PAT(Q)

At Rs 52.11 cr has Grown at 446.4%

NET SALES(Q)

Highest at Rs 919.96 cr

PBDIT(Q)

Highest at Rs 184.25 cr.

PBT LESS OI(Q)

Highest at Rs 109.32 cr.

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Viyash Scientifi

Net Sales - Quarterly
At Rs 919.96 cr has Grown at 129.02%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 12.69 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 109.32 cr has Grown at 629.29%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 52.11 cr has Grown at 446.4%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 919.96 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 184.25 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 109.32 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Here's what is not working for Viyash Scientifi

Non Operating Income - Quarterly
Highest at Rs 15.92 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income